Application Nr Approved Date Route Status External Links
ANDA204806 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Atazanavir Capsule Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection For Patients 6 Years And Older Weighing At Least 15 Kg. Limitations Of Use: Atazanavir Capsules Are Not Recommended For Use In Pediatric Patients Below The Age Of 3 Months Due To The Risk Of Kernicterus. Use Of Atazanavir Capsules/ritonavir In Treatment-Experienced Patients Should Be Guided By The Number Of Baseline Primary Protease Inhibitor Resistance Substitutions [See Microbiology (12.4) ] . Atazanavir Capsule Is A Protease Inhibitor Indicated For Use In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection For Patients 6 Years And Older Weighing At Least 15 Kg. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Atazanavir Sulfate ATAZANAVIR SULFATE ZINC3941496

Comments